Core Components

China’s NMPA UDI database lists Neuracle’s NEO-M and NEO-M Pro hand motor function compensation system models under registration certificate 国械注准20263120537, and K1014-25 and K1014-35 implantable EEG electrode kits under 国械注准20263120536. The descriptions identify the system’s implantable components, EEG transceiver, pneumatic glove and software.

Moving BCI computation from the cloud onto devices still requires trade-offs among energy use, response latency, and accuracy. A systematic review surveys edge-AI accelerators for brain-computer interfaces and emphasizes joint algorithm and chip design to reduce both computational demands and data-movement overhead. It discusses algorithmic compression, compute-in-memory, and neuromorphic architectures, identifying on-device adaptive learning as important for addressing neural signal variability across sessions. The author also proposes privacy-preserving hardware and multimodal sensor fusion as development directions, not as established evidence of clinical effectiveness or security.

Researchers developed a reconfigurable microelectrode array chip with 24,576 electrodes that supports neurotransmitter-related chemical sensing and neural current recording on the same hardware platform. Experiments demonstrated single-electrode electrochemical sensing, quantitative dopamine detection in prepared solution, and dynamic electrochemical imaging. The team also recorded spontaneous extracellular biocurrent from primary neurons. Chemical and electrical recording support 24 and 384 simultaneous output channels, respectively, rather than simultaneous readout from every electrode. The authors propose the platform for studying interactions between chemical and electrical signaling; the reported validation is at the sample and cellular levels.

A perspective paper proposes designing neural implants as functional tissues made of living cells, rather than solely as electrodes connecting to nerves. Called Cybertissue Neuroprosthetics, the concept aims for structural and functional integration with the host nervous system to support long-term neuromodulation and information exchange. It optionally incorporates minimal nanoelectronics, nanomaterials, or genetic modifications while seeking to reduce foreign materials and use cellular signaling mechanisms. The author proposes this approach to address interface deterioration during long-term implantation, but lifetime integration remains a goal, not an established device capability or clinical outcome.

Electrodes for non-invasive brain-computer interfaces have long traded off conductivity, conformity to the skin and durability. A conductive hydrogel made by in situ directional freezing copolymerization forms vertically aligned ion channels and an interconnected nanoporous network, giving it higher conductivity than conventional hydrogel electrodes. In preliminary P300 and steady-state visual evoked potential (SSVEP) experiments, it recorded signals comparable in quality to conventional wet- and dry-electrode benchmarks, while also offering a tissue-matched compressive modulus, high stretchability, skin adhesion and rapid self-healing. The paper presents these experiments as a feasibility demonstration and reports no data on long-term wear stability, scaled-up fabrication or human clinical trials.

Neuracle Medical Technology (Shanghai) Co., Ltd. has registered a cortical electrode, model 1014-35, in the medical device unique identification (UDI) database of China's National Medical Products Administration (NMPA), under registration certificate Guoxiezhuzhun 20263120536. Neuracle's product line spans EEG acquisition equipment and implantable electrodes. The electrode belongs to an implantable EEG electrode kit (cortical electrode, blank electrode, electrode dilator, tunneler, torque wrench, lead fixation clip, fixation screws and electrode protective sleeve) that holds its own registration certificate and is also a component of an implantable BCI hand motor function compensation system. That system comprises a BCI implant, the electrode kit, an EEG signal transceiver, a pneumatic glove, a single-use surgical toolkit, and three software packages for EEG decoding, medical testing and clinical management.

On May 8, 2026, Apple notified the European Commission under Article 14 of the Digital Markets Act that it would, through a subsidiary, acquire certain assets of Sonera and offer jobs to and hire certain Sonera employees. The deal value was not disclosed and neither party has announced it; May 8 is the filing date, and no closing date has been made public. The Commission describes Sonera as a company developing chip-scale magnetic sensors. Founded in 2018 in Berkeley, California, as a University of California, Berkeley spinout, Sonera builds acoustically driven ferromagnetic resonance magnetic sensors that operate at room temperature and has raised about $20 million.

To move from lab prototypes to long-term clinical systems, implantable brain-computer interfaces must place thousands to millions of electrodes several millimeters to centimeters deep in brain tissue without heating it by more than about 1 degree Celsius. This review benchmarks inductive, mid-field, RF, ultrasonic, magnetoelectric, optical, UWB and electro-quasistatic wireless links against three clinical axes (depth, size and data rate), noting that almost every clinically relevant implant is weakly coupled, with coupling coefficients of only 10^-3 to 10^-1. Within a communication budget of about 10 mW, narrowband high-Q links suit power transfer and low-speed data, but at 1-10 nJ/b they cannot deliver the more than 10 Mbps to tens of Gbps uplinks that interfaces with a thousand or more channels require. The study is a preprint and has not been peer reviewed.

A chip-level design for a one-way impulse-radio ultra-wideband (IR-UWB) uplink brings the implant's packet engine and free-running transmitter, a tissue-proxy channel, and the wearable's mixed-signal receiver and digital baseband under a single layered protocol. It aims to keep circuit partitioning, waveform mapping, packet handling and failure behavior consistent for high-rate neural telemetry. The work is a preprint and has not been peer reviewed.

Neuracle Medical Technology (Shanghai) Co., Ltd. registered an Implantable EEG Electrode Kit in the NMPA Medical Device Unique Identification database. The model is K1014-15, and the registration certificate number is 国械注准20263120536. The listed kit includes a cortical electrode, a blank electrode, and surgical and fixation components. It is both a product with its own registration certificate and a component of an implantable brain-computer interface hand motor function compensation system. The system also includes an implant, an EEG transceiver, a pneumatic glove device, and software. This entry identifies the product and its composition; it does not establish the complete system's registration status or clinical performance.

Neuracle Medical Technology (Shanghai) Co., Ltd. registered the K1014-25 Implantable EEG Electrode Kit in the NMPA Medical Device Unique Identification database. Its registration certificate number is 国械注准20263120536. According to the company's registered description, the kit includes a cortical electrode, a blank electrode, and associated tools and fixation components. It is both a product with its own registration certificate and a component of an implantable brain-computer interface hand motor function compensation system. The entry also lists the system's EEG transceiver, pneumatic glove device, and software. It identifies the kit and its relationship to the system; UDI registration itself does not validate clinical efficacy or safety.

Neuracle Medical Technology (Shanghai) Co., Ltd. registered the K1014-35 Implantable EEG Electrode Kit in the NMPA Medical Device Unique Identification database. Its registration certificate number is 国械注准20263120536. The company's description lists a cortical electrode, a blank electrode, and associated tools and fixation components. It describes the kit as both a product with its own registration certificate and a component of an implantable brain-computer interface hand motor function compensation system. The notes also list an EEG transceiver, a pneumatic glove device, and software within that system. The kit's UDI entry alone does not confirm the complete system's registration status or clinical performance.

On 31 March 2026 Hubei's provincial science and technology department approved the formation of a provincial brain-computer interface technology innovation centre, led by Tongji Hospital in Wuhan together with 12 organisations including Huazhong University of Science and Technology and Hubei Optics Valley Laboratory. Chinese reports describe it as the country's first provincial BCI platform positioned as comprehensive and full-chain. Its stated priorities are neural signal decoding, domestic sourcing of core components, and refining both non-invasive and implanted approaches. It is headed by Tang Zhouping, the hospital's party secretary.